Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof

Details for Australian Patent Application No. 2006279906 (hide)

Owner The Rockefeller University Alnylam Pharmaceuticals, Inc.

Inventors Rajeev, Kallanthottathil G.; Stoffel, Markus; Manoharan, Muthiah

Agent Pizzeys

Pub. Number AU-B-2006279906

PCT Pub. Number WO2007/021896

Priority 60/763,201 26.01.06 US; 60/706,866 10.08.05 US; 60/731,554 28.10.05 US

Filing date 10 August 2006

Wipo publication date 22 February 2007

Acceptance publication date 10 May 2012

International Classifications

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/021896 Priority application(s): WO2007/021896

10 May 2012 Application Accepted

  Published as AU-B-2006279906

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006279929-Treatment of proliferative disorders

2006279901-A wireless communication device using adaptive beamforming